News
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
AstraZeneca has formed a partnership with Regeneron to investigate the potential of treating obesity using drugs directed at GPR75, a protective gene identified by scientists at the Regeneron ...
Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.
4d
Dealbreaker on MSNDraig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric DrugsThe startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or ...
The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene ...
The race to develop muscle-preserving treatments alongside popular obesity drugs like Eli Lillys (NYSE:LLY) Zepbound and Novo ...
Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.
Get the latest news and real-time alerts from Eli Lilly and Company (LLY) stock at Seeking Alpha.
Comprehensive coverage of the pharmaceuticals industry. The latest news and developments from the world's leading drug companies, including Pfizer, Johnson & Johnson, AstraZeneca and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results